With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Each week Hot off the Wire looks at a variety of stories in business, science, health and more. This week's headlines include: Luigi Mangione's lawyers seek to delay his state and federal trials. As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results